← Back to headlines
Summit Therapeutics Focuses on Ivonescimab Trial for Non-Small Cell Lung Cancer
Summit Therapeutics Inc. is concentrating its efforts on the clinical trial of Ivonescimab, a drug being developed for the treatment of non-small cell lung cancer.
2 Mar, 07:56 — 2 Mar, 07:56
Sources
Showing 1 of 1 sources
